First-in-human clinical trial for a vaccine to treat opioid use.
The Pharma Data
SEPTEMBER 7, 2021
Marco Pravetoni, PhD, a leading expert of biologics for the treatment of substance use disorders and developer of the vaccine candidate, is an associate professor of pharmacology and medicine at the University of Minnesota Medical School. The study plans to enroll up to 45 volunteers.
Let's personalize your content